HighField Biopharmaceuticals
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A clinical-stage biotech developing engineered antibody therapies for cancer and autoimmune diseases.
OncologyImmunology
Technology Platform
A proprietary antibody engineering platform for developing humanized and bispecific antibodies with optimized pharmacokinetics and efficacy.
Opportunities
Large and growing domestic oncology market with significant unmet need for novel targeted therapies.
Risk Factors
Clinical failure of lead candidates and intense competition from similar mechanisms of action.
Competitive Landscape
Competes in a crowded field of Chinese biotechs developing antibody therapies, requiring clear differentiation in efficacy or safety.